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Objective: To assess in situ chondrocyte viability following exposure to a laboratory strain and clinical
isolates of Staphylococcus aureus.
Methods: Bovine cartilage explants were cultured in the presence of S. aureus 8325-4 (laboratory strain),
clinical S. aureus isolates or non-infected culture medium of pH values 7.4, 6.4 and 5.4. All clinical isolates
were isolated from the joint aspirates of patients presenting with S. aureus-induced septic arthritis (SA).
At designated time points, in situ chondrocyte viability was assessed within deﬁned regions-of-interest
in the axial and coronal plane following live- and dead-cell image acquisition using the ﬂuorescent
probes 5-chloromethylﬂuorescein diacetate (CMFDA) and propidium iodide (PI), respectively, and
confocal laser-scanning microscopy (CLSM). Cartilage water content, following S. aureus 8325-4 expo-
sure, was obtained by measuring cartilage wet and dry weights.
Results: S. aureus 8325-4 and clinical S. aureus isolates rapidly reduced in situ chondrocyte viability
(>45% chondrocyte death at 40 h). The increased acidity, observed during bacterial culture, had a
minimal effect on chondrocyte viability. Chondrocyte death commenced within the superﬁcial zone (SZ)
and rapidly progressed to the deep zone (DZ). Simultaneous exposure of SZ and DZ chondrocytes to
S. aureus 8325-4 toxins found SZ chondrocytes to be more susceptible to the toxins than DZ chon-
drocytes. Cartilage water content was not signiﬁcantly altered compared to non-infected controls.
Conclusions: Toxins released by S. aureus have a rapid and fatal action on in situ chondrocytes in this
experimental model of SA. These data advocate the prompt and thorough removal of bacteria and their
toxins during the treatment of SA.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Septic arthritis (SA), deﬁned as joint inﬂammation secondary to
bacterial infection1, can be a highly destructive disease2. In developed
countries, the incidence of SA ranges from 2 to 10 cases/100,000
persons3e6 and affects all age groups, with incidence peaks in chil-
dren and the elderly7. Although any joint can be affected, there is a
propensity for lower limb involvement8,9. The majority of cases arise
through the haematogenous spread of bacteria to the joint10 butI.D.M. Smith, Department of
ng, 49 Little France Crescent,
0-8251; Fax: 44-(0)-131-650-
, idmsmith@hotmail.com
s Research Society International. Pdirect joint-colonisation may also occur following intra-articular in-
jections, surgical instrumentation or penetrating trauma4.
Despite current treatment strategies, which include intravenous
antibiotics coupled with joint lavage5, retrospective studies indi-
cate that some degree of permanent joint damage, involving direct
cartilage injury, develops in up to 50% of cases11e13. This suggests
that chondrocyte death may occur during SA, as these cells are the
only living agents capable of cartilage maintenance14. However,
chondrocyte loss and subsequent cartilage degeneration may not
be clinically evident for years. Thus, it is possible that supposedly-
treated SA may have seeded the foundations for future problems
e.g., early-onset osteoarthritis.
Numerous bacterial species are capable of inducing SA11. Themost
commonly isolated organism however is Staphylococcus aureus, ac-
counting for 40e65% of cases15,16. S. aureus is a highly virulent
pathogen associated with awide range of serious infections17e19 andublished by Elsevier Ltd. All rights reserved.
Table I
Source and details of S. aureus clinical isolates utilised in this study
Isolate Gender Age Source
36V Male 46 Right hip
28G Male 74 Right wrist
12R Male 69 Left knee
I.D.M. Smith et al. / Osteoarthritis and Cartilage 21 (2013) 1755e17651756produces a diverse array of toxins20. Studies investigating a variety of
S. aureus-related infections have implicated a group of exotoxins
(including alpha(a)-, beta(b)-, gamma(g)- and delta(d)-haemolysin)
as key virulence factors17,18,21,22. Murine models suggest that alpha-
and gamma-haemolysin play an important role in the joint destruc-
tion associated with SA19,23.
This study primarily focuses on S. aureus 8325-4, which is a
laboratory ‘wild-type’ strain. It is a well-characterised prophage-
cured derivative of NCTC832523,24 and produces the major S. aureus
toxins19. NCTC8325 was originally isolated from a sepsis patient in
1960 and its lineage remains a valuable resource for S. aureus
research25. In addition, we have investigated clinical isolates of
S. aureus, isolated from the joint aspirates of patients presenting
with S. aureus-induced SA.
Previous work investigating bacteria and associated toxins has
primarily focused on isolated chondrocytes, cartilage explants or
animal models26,27. Isolated chondrocytes have the advantage of
allowing easier control of experimental conditions but have the
disadvantage of not allowing the study of chondrocytes in their
native extracellular environment. In contrast, chondrocytes within
cartilage remain within their native environment but studies to
date have utilised assays for either the release of extracellular
matrix (ECM) components27,28 or degradative enzymes29 as
experimental end-points. Although these provide an important
indication of cartilage damage, they give no information on chon-
drocyte viability following bacterial exposure. An in vitro model of
SA whereby in situ chondrocyte death can be both directly visual-
ised and quantiﬁed, whilst at the same time allowing better control
of experimental variables, would be highly desirable.
It is likely that there are two major mechanisms to the cartilage
destruction that occurs in SA: (1) bacteria and associated toxins,
and (2) components of the host immune response. However, the
contribution from each of these is currently unknown. This study
focuses on the former and aims to provide fundamental informa-
tion about the effect of S. aureus and its toxins on in situ chon-
drocyte viability separate from the potentially confounding effect of
the host immune response present in animal models. We have used
confocal laser-scanning microscopy (CLSM) to spatially deﬁne and
quantify in situ chondrocyte death in a bovine cartilagemodel of SA,
which is a relatively novel approach. We have also measured
cartilage hydration following bacterial exposure to assess cartilage
integrity, as increased cartilage water content is a sensitive indi-
cator of cartilage matrix disruption30,31.
Our primary hypothesis was that both a laboratory strain and
clinical isolates of S. aureus have a rapid and potent effect on in situ
chondrocyte viability and cartilage integrity. Our secondary hy-
pothesis was that chondrocyte death commences within the su-
perﬁcial zone (SZ) of cartilage and progresses to deeper layers. This
study was conducted to improve our understanding of the inter-
action between bacteria and in situ chondrocytes with a view, ul-
timately, to improving the treatment of SA.
Materials and methods
Biochemicals and solutions
Biochemicals were obtained from Invitrogen Ltd. (Paisley, UK)
unless otherwise stated. The standard tissue culture medium was
serum-freeDulbecco’sModiﬁedEagle’sMedium(DMEM,340mOsm/
Kg H2O; pH7.4) with L-glutamine (4 mM), D-glucose (25 mM) and
sodium pyruvate (1 mM). Penicillin (50 U/ml) and streptomycin
(50 mg/ml) were added for experiments not involving bacterial cul-
ture. DMEM of three pH values was used: pH7.4, pH6.4 and pH5.4
(adjusted using HCl). 5-chloromethylﬂuorescein diacetate (CMFDA)
was prepared in dimethyl sulphoxide (1 mM stock) and propidiumiodide (PI) as an aqueous 1mM stock. Formaldehyde solution (4% v/v
in saline; pH7.4) was obtained from Fisher Scientiﬁc (Loughborough,
UK). The standard bacterial culture media were tryptone soya agar
and broth (TSA, TSB; Oxoid Ltd., Basingstoke, UK).
S. aureus strains and isolates
S. aureus strain 8325-4 was kindly provided by Professor T.J.
Foster, Dept. Microbiology, Trinity College, Dublin, Ireland. A total of
three S. aureus clinical isolates [Table I], isolated from joint aspirates
of patients presenting with S. aureus-induced SA, were obtained.
Bacteria were stored at 80C in 10% v/w skimmed milk (Oxoid
Ltd., Basingstoke, UK).
Preparation of deﬁned bacterial aspirates
When required, bacteria were thawed and streaked onto TSA
plates and incubated (24 h; 37C). TSB was then inoculated with
several individual bacterial colonies from the TSA plate of a given
bacterial strain/isolate and incubated (37C) in a shaking incubator
for 24 h. Serial dilutions, to a maximum of 106, were performed on
the 24 h TSB culture in order to calculate the number of colony
forming units (cfu) in 1 ml of 24 h TSB. Dilutions (100 ml of 104,
105, and 106) were spread onto TSA plates and incubated (37C;
24 h). Colonies were then determined and counted using a colony
counter (Stuart, Bibby Scientiﬁc, Stone, UK). Bacterial counts were
performed on a number of cultures and a count of approx.
1.0 109 cfu/ml was consistently obtained. The 24 h culture of each
strain grown in 10 ml TSB was then diluted in DMEM to produce a
ﬁnal bacterial concentration of approx. 1.0  105 cfu/ml DMEM.
Bovine osteochondral explants
Metacarpophalangeal joints of 3-year-old cows were washed,
skinned, de-hoofed and opened under sterile conditions within
6 h of slaughter. Only healthy joints, with no evidence of cartilage
damage/degeneration, were used. Osteochondral explants were
harvested from the convex articular surface32. For the experiment
investigating the sensitivity of SZ chondrocytes to bacterial toxins,
subchondral bone-free explants were obtained.
Bacterial culture and pH studies
For each experiment, osteochondral explants from each joint
were placed into separate tissue culture ﬂasks containing DMEM
(5 ml). Thereafter, 25 ml (2.5  103 cfu) of a given bacterial aspirate
was added to each ﬂask. This concentration was chosen as it was in
the range used by previous direct joint-inoculation in vivo studies
of SA33,34. In addition, our preliminary experiments identiﬁed that
this number of bacteria produced a measurable response that was
neither overwhelming nor weak. Flasks were then incubated (37C;
5% CO2; 40 h). A similar experiment was conducted whereby
cartilage explants were cultured in non-infected DMEM at pH
values of 7.4, 6.4 or 5.4. For a post-infection long-term chondrocyte
viability study, explants were initially cultured with S. aureus 8325-
4 for 40 h. The infected culture mediumwas then aspirated and the
cartilage rinsed with normal saline (0.9% w/v; Baxter’s Healthcare,
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Fresh DMEM containing penicillin and streptomycin was then
added, and the culture resumed for a further 14 days.
Bacterial supernatant studies
The 40hr cultures of S. aureus 8325-4 were pooled and centri-
fuged (3400 g; 10 min) to separate bacteria from toxins. The su-
pernatant, containing the toxins, was harvested and ﬁlter-sterilised.Fig. 1. Thepreparationof osteochondral explants for axial and coronal CLSMimaging (A). Axial a
deadcell counts performedwithin these regionsby thresholding voxel intensity (seeMaterials an
identiﬁcation. A 50% ﬁeld-of-view region of interest was utilised for all axial images in order toSubchondral bone-free explants were then exposed to the super-
natant (37C; 5% CO2) over a 6 h time-course.
Fluorescent probes and ﬁxation
At 0 and 6 h (supernatant study); 18, 24 and 40 h (bacterial
culture, pH studies); and 16 days (post-infection study), explants
were aseptically removed and trimmed to create two straight edges
[Fig. 1(A)]. Explants were then incubated (1 h; 21C) in penicillin-ndcoronal regionsof interest (areaswithinbrokenyellowboxes)were established and live/
dmethods) (B). Livinganddeadcellsweremarkedblueandyellow, respectively, following
safely avoid the dead-cell artifact produced by the cut-edge (*) (white bar ¼ 100 mm).
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(10 mM), which labels living or dead chondrocytes green or red,
respectively32,35. Explants were subsequently ﬁxed (4% formalde-
hyde; 24 h) prior to storage (4C) in phosphate-buffered saline
(PBS). For microscopy, explants were secured to the base of a Petri
dish with Blu Tack (Bostik, Leicester, UK) and re-submerged in PBS.
Cartilage water content
Cartilage explants were cultured with S. aureus 8325-4 or non-
infected DMEM of pH7.4 or 5.4. At 0, 24 and 40 h, explants were
aseptically retrieved from the ﬂasks and excess moisture removed
by placing the explants brieﬂy between folded ﬁlter paper. The ex-
plants were then placed in pre-weighed glass vials, weighed (total
wet weight (a)) and dried at 60C until constant weight (total dry
weight (b))35. Water content was calculated as: ((a  b)/a)  100%.
CLSM
An upright Zeiss LSM510 Axioskop (Carl Zeiss Ltd., Welwyn
Garden City, UK) CLSM with a 10/0.3 dry objective, was used to
acquire optical sections of CMFDA- and PI-labelled in situ chon-
drocytes32,35. Articular cartilage is loosely characterised into three
zones on the basis of depth-associated variations in chondrocytes
and ECM: superﬁcial (SZ; 0e10% depth from the articular surface),
middle (MZ; 10e40%) and deep zones (DZ; 40e100%)36,37 [Fig.1(A)].
Depending on the experiment, images were obtained in either the
axial or coronal plane [Fig.1(A)]. For axial images, the focal planewas
moved through the tissue in 10 mm increments from the articular
surface i.e., the z-direction, normally to a depth of 100 mm, thereby
enabling detailed visualisation of chondrocytes within the entirety
of the SZ and a small portion of theMZ. For coronal images, the focal
plane was moved in a similar manner but from the ‘cut-edge’ into
the tissue i.e., the y-direction to a depth of 100 mm, thereby enabling
visualisation of the full cartilage thickness [Fig. 1(A)]. Each optical
section measured 921 mm  921 mm with an image resolution of
1024  1024 pixels.
Quantiﬁcation of in situ chondrocyte death
For reconstructed three-dimensional axial projections, the per-
centage cell death ((number of dead cells/total number of living and
dead cells)  100) was calculated within a 50% ﬁeld-of-view region
of interest (ROI) measuring 921  461  100 mm (xeyez axes,
respectively) [Fig. 1(B)] using Volocity 4 (Improvision, Coventry,
UK) imaging software. This was created in order to avoid the cell-
death artefact at the cut-edge32 [Fig. 1(B)]. For coronal pro-
jections, percentage cell death was quantiﬁed at 100 mm intervals,
within an ROI measuring 921  100  100 mm (xeyez axes,
respectively), to a depth of 400 mm from the cartilage surface
[Fig. 1(B)]. Although the full thickness of bovine cartilage is usually
>500 mm38, in some explants the osteochondral junction was be-
tween 400 and 500 mm. Thus, to avoid potential overlap of the
osteochondral junction, the maximum depth limit for analysis was
set at 400 mm, which remained within the DZ. For each ROI, objects
(individual cells) in both the green (living) and red (dead) channels
were counted on the basis of percentage voxel (volumetric pixel)
intensity using an established protocol39.
Statistical analysis
Statistical analyses were performed using SigmaPlot version 12
(Systat Software Inc., Chicago, USA). N refers to the number of feet
from separate animals (independent experiments) and n refers to
the number of individual explants analysed per experimental groupat each time point. Values of all replicates of explants for an
experiment from the same animal were averaged to obtain a single
observation for that animal. All data were tested for normality
(ShapiroeWilk test) and equality of variance (Levene’s test).
Thereafter, parametric data were analysed using either one-way
between-groups ANOVA (clinical isolate, cartilage water content
and DMEM coronal studies), with post hoc Dunnett’s or Bonferroni
tests, or paired and unpaired Student’s two-tailed t tests (8325-4 vs
DMEM axial study, post-infection viability study and SZ study).
One-way between-groups KruskaleWallis ANOVA (pH study), with
post hoc Dunn’s test, or ManneWhitney U test (8325-4 vs DMEM
coronal study) were used to analyse non-parametric data. Data are
presented as means  95% conﬁdence interval (CI) with the level of
signiﬁcance set at P < 0.05.Results
S. aureus 8325-4 rapidly reduced in situ chondrocyte viability
To test our bovine cartilage explant model of SA, in situ chon-
drocyte deathwas quantiﬁed in the axial plane using osteochondral
explants cultured in the presence or absence (DMEM control) of
S. aureus 8325-4. In explants cultured with S. aureus 8325-4,
chondrocyte death increased relatively slowly between 18 and
24 h [Fig. 2(A)]. However, between 24 and 40 h there was a rapid
reduction in chondrocyte viability with 88.27  20.9% chondrocyte
death at 40 h. In comparison, there was negligible chondrocyte
death at 40 h in the control group (0.13  0.2%) with the difference
in chondrocyte viability between the two groups at 40 h being
signiﬁcant [P < 0.001; Fig. 2(A and B)].Reduced culture medium pH had a minimal effect on in situ
chondrocyte viability
During the above experiments, the culture medium became
progressively acidic [Fig. 3(A)], with pH values of approx. 6.4 and
5.4 at 24 and 40 h, respectively. There was the possibility that
chondrocyte death might be due, in part, to acidic medium pH,
induced by bacterial growth and metabolism40. To assess the
contribution of acidity on chondrocyte viability, explants were
incubated in media of pH7.4, 6.4 and 5.4. Although there was no
difference in chondrocyte viability between the groups at
18 h (P ¼ 0.18) and 24 h (P ¼ 0.14), at 40 h there was a small but
signiﬁcant increase in chondrocyte death in the explants exposed
to pH5.4 (4.73  5.6%; P < 0.01) compared to pH6.4 [0.05  0.05%;
Fig. 3(B)]. The extent of chondrocyte death at pH5.4 (40 h) was
however considerably lower than that inﬂicted by S. aureus 8325-4
[Fig. 2(A)] and therefore contributed nomore than approx. 5% of the
overall 40 h chondrocyte death induced by S. aureus 8325-4.Comparison between S. aureus clinical isolates and S. aureus 8325-4
Although none of the clinical isolates [Table I] were as potent as
S. aureus 8325-4, each isolate produced >45% chondrocyte death at
40 h [Fig. 4(A)]. In contrast, all the clinical isolates had a more
potent effect than S. aureus 8325-4 at 18 and 24 h. There was,
however, variation between the potencies of the clinical isolates at
18 and 24 h [Fig. 4(A and B)]. Statistical tests comparing the clinical
isolates with the DMEM control group demonstrated the 36V
isolate alone to be signiﬁcantly different at 18 h (31.31  9.8%;
P < 0.001), the 28G (58.42  21.8%; P < 0.001) and 36V
(47.51  11.8%; P < 0.001) isolates at 24 h, and all isolates at
40 h [Fig. 4(A)].
Fig. 3. Acidic culture medium induces a small decrease in in situ chondrocyte
viability. Reduced culture medium pH was noted during 40 h S. aureus 8325-4 cul-
ture, as depicted by a change in culture medium colour (DMEM contains phenol red
which is pH sensitive and progresses through orange to yellow as the immediate
environment becomes more acidic) (A). The bar graph (B) demonstrates in situ
chondrocyte viability, in the absence of bacteria, in pH7.4 (control), 6.4 and 5.4
culture medium (N ¼ 6[n ¼ 6]; numerical P values represent one-way between-
groups KruskaleWallis ANOVA; **P < 0.01 pH5.4 vs pH6.4 by post hoc Dunn’s test).
Values are means  95% CI.
Fig. 2. Increased in situ chondrocyte death by S. aureus 8325-4. Line graph (A) shows
chondrocyte death in the presence or absence (DMEM control group) of S. aureus
8325-4 (N ¼ 4[n ¼ 8]; P values represent 8325-4 vs DMEM control group by unpaired
Student’s two-tailed t test). The CLSM images (B) display the marked difference be-
tween the S. aureus 8325-4 and DMEM control groups at 40 h (white bar ¼ 100 mm).
Values are means  95% CI.
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within the SZ of osteochondral explants and progressed to deeper
zones
In order to assess chondrocyte viability throughout articular
cartilage following bacterial exposure, a separate population of
explants was cultured in either the presence or absence of S. aureus
8325-4, but here they were imaged and quantiﬁed in the coronal
plane [Fig. 1(A and B)]. In the absence of bacteria, there was no
change in chondrocyte viability over time [Fig. 5(A)]. The chon-
drocyte death, which was present throughout, was due to the
scalpel cuts as previously reported32. Chondrocytes within the
most superﬁcial 100 mm were more susceptible to cutting traumathan those within deeper layers. With the exception of 18 h, there
was signiﬁcantly more chondrocyte death within the superﬁcial
100 mm, compared to deeper intervals, at each time point
[Fig. 5(A)]. However, chondrocyte death did not exceed 13% within
any of the intervals studied. In comparison, there was progressive
chondrocyte death in explants exposed to S. aureus 8325-4
[Fig. 5(B)] which commenced within the SZ and rapidly progressed
to deeper layers [Fig. 5(B and C)].
It was hypothesised that the extensive chondrocyte death
induced by S. aureus 8325-4 at 40 h [Fig. 5(B and C)] might
compromise cartilage integrity. An early feature of cartilage
degeneration is increased cartilage water content30,41. Accordingly,
this was measured in explants cultured in the presence or absence
of S. aureus 8325-4 at 24 and 40 h. In addition, explants incubated at
pH5.4, previously shown to induce a small but signiﬁcant decline in
chondrocyte viability [Fig. 3(B)], were also investigated. There was
Fig. 4. S. aureus clinical isolates have a damaging effect on in situ chondrocyte viability. The bar graph (A) displays a signiﬁcant difference between the DMEM control group and the
clinical isolates from 18 h onwards (N ¼ 4[n ¼ 8]; numerical P values represent one-way between-groups ANOVA; ***P < 0.001 vs DMEM control group by post hoc Dunnett’s test).
The panels (B) show CLSM images of explants exposed to the clinical isolates with marked chondrocyte death induced by all isolates at 40 h in comparison to the DMEM control
group. However, the potencies of the isolates vary at 18 and 24 h (white bar ¼ 100 mm). Values are means  95% CI.
I.D.M. Smith et al. / Osteoarthritis and Cartilage 21 (2013) 1755e17651760no difference in the water content of the explants between the
groups at 24 (P ¼ 0.995) or 40 h (P ¼ 0.46) [Fig. 6].
In order to assess the longer-term effects on chondrocytes
following infection, cartilage explants were cultured with S. aureus
8325-4 for 40 h prior to rinsing with normal saline. Explants were
then incubated in penicillin- and streptomycin-containing DMEM
for a further 14 days. Chondrocyte viability was determined in the
coronal plane at 40 h and 16 days as previously described. The
mean cell death throughout the analysed depth intervals at
40 h was 87.1  20.9%, and this was not signiﬁcantly different at 16
days (91.4  16.9%; P ¼ 0.16 by paired Student’s two-tailed t test;
N ¼ 4[n ¼ 8]). This demonstrated that the PI-stained chondrocytes
at 40 h were dead and incapable of labelling green with CMFDA to
indicate that they had recovered viability.SZ chondrocytes were more susceptible to S. aureus 8325-4 toxins
than cells within deeper zones
Chondrocyte death, following exposure to S. aureus 8325-4,
commenced within the SZ [Fig. 5(B and C)]. However, as osteo-
chondral explants were utilised it could not be concluded that SZ
chondrocytes were more susceptible to S. aureus 8325-4 toxins as
the subchondral bone may have acted as a diffusion barrier to
bacterial toxins, thereby protecting DZ chondrocytes [Fig. 7(A)]. In
order to assess the susceptibility of SZ and DZ chondrocytes to
S. aureus 8325-4 toxins, subchondral bone-free cartilage explants
were exposed to S. aureus 8325-4 toxins for 6 h and chondrocyte
death analysed within the SZ and DZ [Fig. 7(A)]. In the absence of
subchondral bone, there was equal toxin exposure to chondrocytes
Fig. 5. The zonal pattern of chondrocyte death following exposure to S. aureus 8325-4. In the absence of bacteria (A), chondrocyte death at each time point was minimal and
consistent within each depth interval. Apart from 18 h, there was signiﬁcantly increased chondrocyte death within the ﬁrst 100 mm in comparison to deeper zones (N ¼ 4[n ¼ 8];
numerical P values represent one-way between-groups ANOVA; *P < 0.05; **P < 0.01; ***P < 0.001 vs 0e100 mm depth interval by post hoc Bonferroni test). In those explants
exposed to S. aureus 8325-4 (B), chondrocyte death commenced within the SZ and extended to deeper layers (N ¼ 4[n ¼ 8]; P < 0.05 vs comparable depth interval in DMEM control
group by ManneWhitney U test). The panels (C) display CLSM images of explants cultured in either the presence or absence of S. aureus 8325-4 and provide a visual representation
of chondrocyte death commencing within the SZ and progressing (white arrows) to deeper layers (white bar ¼ 100 mm). Values are means  95% CI.
I.D.M. Smith et al. / Osteoarthritis and Cartilage 21 (2013) 1755e1765 1761within the SZ and DZ [Fig. 7(A)]. At 0 h, chondrocyte death was
comparable in the SZ and DZ (P ¼ 0.36) [Fig. 7(B and C)]. However,
after 6 h incubation with S. aureus 8325-4 toxins, 49.1 1.2% of the
SZ cells were dead compared to only 18.67  4.3% in the DZ
(P < 0.001). There was signiﬁcantly more chondrocyte death in the
SZ at 6 h compared to 0 h (P < 0.001). In contrast, there was min-
imal difference in chondrocyte viability between 0 and 6 h in the DZ
(P ¼ 0.57). SZ chondrocytes were therefore considerably more
susceptible to S. aureus 8325-4 toxins than DZ chondrocytes.Discussion
This study utilised CLSM to determine changes to in situ chon-
drocyte viability during exposure to a laboratory strain and clinical
isolates of S. aureus. The results demonstrated that toxins released
by S. aureus have a potent damaging effect on chondrocytes
whereas the increased acidity occurring during bacterial culture
had a minimal effect. Chondrocyte death commenced in the SZ of
cartilage, suggesting that these cells were more susceptible to the
Fig. 6. No change in cartilage water content following 40 h culture in the presence of
S. aureus 8325-4 and pH5.4 culture medium (N ¼ 4[n ¼ 8]; numerical P values
represent one-way between-groups ANOVA). Values are means  95% CI.
I.D.M. Smith et al. / Osteoarthritis and Cartilage 21 (2013) 1755e17651762toxins compared to DZ chondrocytes. Furthermore, despite exten-
sive chondrocyte death induced by S. aureus 8325-4 toxins, carti-
lage water content was not signiﬁcantly altered compared to
non-infected controls.
Cartilage explants from a variety of species have previously been
used for SA research28,29. However, the majority of these studies
utilised assays for either the release of matrix components27,28 or
degradative enzymes29 as experimental end-points, and thus gave
no indication of chondrocyte viability following bacterial exposure.
Lee et al.26 did however investigate the effect of S. aureus and its
toxins on isolated chondrocytes. They demonstrated that chon-
drocytes exposed to a high inoculumof S. aureus underwent necrosis
while chondrocytes exposed to a low inoculum or its ultraﬁltrate
underwent apoptosis. Our application of CLSM permitted the visu-
alisation and quantiﬁcation of the response of chondrocytes within
their native environment and with intact cellematrix interactions.
We utilised S. aureus 8325-4 as it can induce severe SA in animal
models19,23. To our knowledge, no studies have measured the
bacterial concentrations within the infected synovial ﬂuid of
humans presenting with S. aureus-induced SA. Hence, it was
exceedingly difﬁcult to match levels in our experiments with those
in a septic joint. We therefore used a low aspirate concentration
and volume comparable to previous in vivo direct joint-inoculation
studies33. The increase in chondrocyte death was dramatic, with
approx. 90% cells dead at 40 h [Fig. 2(A)]. However, the culture
medium became more acidic [Fig. 3(A)] raising the possibility that
cell death may, in part, be due to elevated medium acidity. How-
ever, control experiments established that there was a minimal
effect on chondrocyte viability at reduced pH [Fig. 3(B)]. This may
reﬂect the membrane transport adaptations present in articular
chondrocytes required for survival in the relatively acidic envi-
ronment of the ECM42.
One potential criticism of the use of S. aureus 8325-4 is that it
may have become considerably distant, in terms of cartilage
damaging potential, compared to strains of S. aureus currently
isolated from patients presenting with SA. However, we demon-
strated that although S. aureus 8325-4 was more potent than
clinical isolates at 40 h, the latter still exerted a strong effect (>45%
chondrocyte death) [Fig. 4(A)]. Indeed, there were differences be-
tween all the isolates at each time point [Fig. 4(A and B)] but thiswas expected, as different isolates will have different growth curves
and toxin production capabilities.
The S. aureus 8325-4 coronal study demonstrated that chon-
drocyte death commenced within the SZ and spread to deeper
layers [Fig. 5(B and C)]. This observation could potentially be
explained by the diffusion of bacterial toxins from the articular
surface through cartilage. However, when chondrocytes within the
SZ and DZ were exposed simultaneously to S. aureus 8325-4 toxins
[Fig. 7(A)] there was signiﬁcantly more cell death in the surface
compared to the deeper zones [Fig. 7(B and C)], suggesting that SZ
chondrocytes were inherently more sensitive to S. aureus toxins.
We do not, at present, have an explanation for this observation but
it could arise from differences in the permeability of the ECM to
toxin diffusion, and/or properties of the resident chondrocytes in
the various zones. In any event, due to the proximity between the
sensitive SZ chondrocytes and the cartilage/synovial ﬂuid interface,
rapid and thorough removal of bacteria and their toxins during
surgical washout would be particularly important.
At the end of the 40 h time-course experiments with S. aureus
8325-4, although there was almost complete chondrocyte death
throughout the cartilage [Fig. 5(B and C)], the tissue appeared
macroscopically normal. Furthermore, there was no signiﬁcant
change to cartilage water content after bacterial toxin exposure
[Fig. 6] and no recovery in chondrocyte viability following rinsing
with saline and antibiotic treatment. Chondrocytes in cartilage do
not normally divide once skeletal maturity is reached14,43 and thus
cartilage devoid of chondrocytes will inevitably become degen-
erate, as the maintenance of the ECM will be lost. There is a risk
therefore that following a supposedly-treated episode of SA, ra-
diographs without any joint space abnormality will be wrongly
interpreted as showing normal, biomechanically competent carti-
lage whereas in fact the progressive degeneration and loss of this
cartilage would be inevitable. We are not aware of any human
studies investigating the time-course of cartilage loss in tissue
devoid of chondrocytes. However, Simon et al.44 investigating the
long-term effect of localized cryotherapy-induced chondrocyte
death in lapine articular cartilage in vivo, demonstrated histologi-
cally that the cartilage was structurally intact at 6 months despite
the absence of living chondrocytes. Nevertheless, by 12 months
extensive cartilage ﬁbrillation and softening were evident, which
are considered to be amongst the ﬁrst macroscopic changes asso-
ciated with degenerative joint disease45.
The interpretation of our experiments had the beneﬁt that the
host immune response was not involved in chondrocyte death.
Following bacterial joint colonisation in vivo, inﬂammatory cyto-
kines are released into the joint by synovial cells and there is an
accompanying inﬂux of host inﬂammatory cells2. Through opsoni-
zation and phagocytosis, the immune response ultimately acts to
remove bacteria. However, evidence from animal studies suggests
that the immune response may paradoxically contribute further to
cartilage destruction2,46. At present, it remains unknown as towhat
extent in vivo chondrocyte death and subsequent cartilage damage
is due to bacteria and their products, andwhat is due to the immune
response. The ﬁndings from an in vivo lapine study of SA by Smith
et al.47 support a signiﬁcant role of bacteria and their soluble toxins
bydemonstrating that theoverall cartilagedestruction, asmeasured
by proteoglycan and collagen loss, declined the earlier antibiotics
were administered.We conclude that it is highly likely that bacterial
toxins have a signiﬁcant effect on chondrocyte viability in vivo.
This study has provided new insights into chondrocyte death
following cartilage exposure to S. aureus and builds upon previous
work highlighting damage to the ECM. By identifying the factors
that cause chondrocytes within some cartilage zones to be more
susceptible to toxins than others and characterising the toxin-
induced cell death pathway, treatment strategies may be
Fig. 7. Increased susceptibility of SZ chondrocytes to S. aureus 8325-4 toxins. Subchondral bone-free explants (A) were exposed to S. aureus 8325-4 toxins for 6 h and chondrocyte
viability was assessed within deﬁned regions of interest (dashed yellow boxes). The bar chart (B) demonstrates no difference in chondrocyte viability between the SZ and DZ at
0 h (N ¼ 4[n ¼ 8]; P ¼ 0.36 by unpaired Student’s two-tailed t test). However, at 6 h there was signiﬁcantly more chondrocyte death within the SZ in comparison to the DZ
(P < 0.001). The CLSM reconstructions (C) provide a clear visual representation of the increased susceptibility of SZ chondrocytes to S. aureus 8325-4 toxins (white bar ¼ 100 mm).
Values are means  95% CI.
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mate goal of reducing the extent of cartilage destruction during and
after an episode of SA.Author contributions
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